Adrenoleukodystrophy Clinical Trials

4 recruiting

Adrenoleukodystrophy Trials at a Glance

9 actively recruiting trials for adrenoleukodystrophy are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Paris, Philadelphia, and Minneapolis. Lead sponsors running adrenoleukodystrophy studies include Beijing Tiantan Hospital, Children's Hospital of Philadelphia, and Assistance Publique - Hôpitaux de Paris.

Browse adrenoleukodystrophy trials by phase

Treatments under study

About Adrenoleukodystrophy Clinical Trials

Looking for clinical trials for Adrenoleukodystrophy? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Adrenoleukodystrophy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Adrenoleukodystrophy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

The Myelin Disorders Biorepository Project

AdrenoleukodystrophyCockayne SyndromeRefsum Disease+63 more
Children's Hospital of Philadelphia12,000 enrolled23 locationsNCT03047369
Recruiting

Modeling Macrophages Activation Pattern in X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy and Adult Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia

AdrenoleukodystrophyAdrenomyeloneuropathyMetachromatic Leukodystrophy
Assistance Publique - Hôpitaux de Paris100 enrolled2 locationsNCT04925349
Recruiting
Not Applicable

IT and IV Lentiviral Gene Therapy for X-ALD

X-linked Adrenoleukodystrophy
Shenzhen Geno-Immune Medical Institute30 enrolled1 locationNCT03727555
Recruiting
Phase 1

UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells

Batten DiseaseAdrenoleukodystrophyPelizaeus-Merzbacher Disease+9 more
Joanne Kurtzberg, MD40 enrolled1 locationNCT02254863
Recruiting

A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel

Cerebral Adrenoleukodystrophy (CALD)
Genetix Biotherapeutics Inc.120 enrolled3 locationsNCT06224413
Recruiting

Adrenoleukodystrophy National Registry Study

AdrenoleukodystrophyALD (Adrenoleukodystrophy)Cerebral Adrenoleukodystrophy
Masonic Cancer Center, University of Minnesota1,000 enrolled1 locationNCT03789721
Recruiting

Quality of Life in Women with X-linked Adrenoleukodystrophy

X-linked Adrenoleukodystrophy
Leipzig University Medical Center200 enrolled1 locationNCT04675749
Recruiting

Disease Progression in Women With X-linked Adrenoleukodystrophy

X-linked Adrenoleukodystrophy
Minoryx Therapeutics, S.L.40 enrolled1 locationNCT06178120
Recruiting

Registry of X-linked Adrenoleukodystrophy

X-linked Adrenoleukodystrophy
Beijing Tiantan Hospital200 enrolled1 locationNCT05939232